Use of Anti-Cytokine Therapy in Kidney Transplant Recipients with COVID-19

In the context of the coronavirus disease 2019 (COVID-19) pandemic, we aimed to evaluate the impact of anti-cytokine therapies (AT) in kidney transplant recipients requiring hospitalization due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This is an observational retros...

Descripción completa

Detalles Bibliográficos
Autores principales: Bodro, Marta, Cofan, Frederic, Ríos, Jose, Herrera, Sabina, Linares, Laura, Marcos, María Angeles, Soriano, Alex, Moreno, Asunción, Diekmann, Fritz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067800/
https://www.ncbi.nlm.nih.gov/pubmed/33917093
http://dx.doi.org/10.3390/jcm10081551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067800/
https://www.ncbi.nlm.nih.gov/pubmed/33917093
http://dx.doi.org/10.3390/jcm10081551

Ejemplares similares